Dr. Robert Lanza from little Advance Cell Technology and Dr. Steve Bauer, chief of Cell and Tissue Therapy division at the mighty FDA are 2 of the 8 keynote speakers at the April 6-8, 2010 TRANSLATIONAL REGENERATIVE MEDICINE forum...
When people like Dr. Robert Lanza, from tiny ACTC, and Dr. Steve Bauer, the FDA's chief at the Cell and Tissue division are speaking together --- as KEYNOTE speakers, standing/sitting no more than a few feet from one another --- as AUTHORITATIVE research scientists in the field of STEM CELL, TISSUE, and REGENERATIVE medicine....
.... What does that tell you about Robert Lanza, ACTC, the FDA, and Stem Cell, Tissue, and Regenerative medicine research....?
True investors need to think LONG TERM; yes, at a certain juncture in history it's UNLUCKY to be in a certain kinds of stocks.... like during those glorious Bush-Cheney years, from 2001 to 2009 --- it was JUST THE MOST AWEFUL YEARS to be in EMBRYONIC STEM CELL research, particularly if you're a small start-up biotech company needing federal fundings for DEEP, EXPERIMENTAL clinical work....
But now, the year 2010... with Obama having lifted MOST restrictions on Stem Cell and Embryonic Stem Cell research, with the FDA granting ACTC unique Embryonic Stem Cell RPF program ORPHAN STATUS... with grants and FDA approval for clinical work on the way?
Surely, there's NO BETTER TIME in history, for ACTC, and for Embryonic Stem Cell research!
Keynote speakers and plenary panelists include Steven Bauer, Ph.D., chief of the Cell and Tissue Therapy Branch, FDA Center for Biologics Evaluation and Research;
Juan Enriquez, managing director, Excel Venture Management;
Robert Lanza, M.D., chief scientific officer, Advanced Cell Technology;
Robert Klein, chairman, California Institute for Regenerative Medicine; Richard Caruso, Ph.D., founder and chairman of the board, Integra; Lesa Mitchell, vice president, Kauffman Foundation; Sherrill Neff, founding partner, Quaker BioVentures; and Teruo Okano, Ph.D., professor and director of the Institute of Advanced Biomedical Engineering and Science, Tokyo Women’s Medical University.